LPA Receptors: Subtypes and Biological ActionsJi Woong Choi, Jerold Chun, Tetsuji Mutoh et al.|The Annual Review of Pharmacology and Toxicology|2010Cited by 851
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P <sub>1</sub> ) modulationJi Woong Choi, Jerold Chun, Shannon E. Gardell et al.|Proceedings of the National Academy of Sciences|2010Cited by 578
GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5Chang‐Wook Lee, Jerold Chun, Richard Rivera et al.|Journal of Biological Chemistry|2006Cited by 470
LPA4/GPR23 Is a Lysophosphatidic Acid (LPA) Receptor Utilizing Gs-, Gq/Gi-mediated Calcium Signaling and G12/13-mediated Rho ActivationChang‐Wook Lee, Jerold Chun, Richard Rivera et al.|Journal of Biological Chemistry|2006Cited by 174
Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (Fingolimod) in multiple sclerosisChang‐Wook Lee, Jerold Chun, Ji Woong Choi|Archives of Pharmacal Research|2010Cited by 59